Standardized kidney biopsy protocol is safe in high-risk patients
Results from a prospective study reveal that with standardized precautions, even high-risk patients may safely undergo a kidney biopsy, a cornerstone of kidney diagnostics that is often perceived as dangerous in certain vulnerable patient populations. The findings were presented at ASN Kidney Week 2026, Oct. 22–25.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Diagnostic test could help doctors refine prostate cancer treatment
United Kingdom
-
Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancer
United Kingdom
-
Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggests
United Kingdom
-
US–Mexico border counties face high kidney disease–related mortality and low nephrologist availability
United Kingdom
-
Standard kidney function tests underestimate chronic kidney disease in people with cancer
United Kingdom
-
Melanoma vaccine reduces death or cancer recurrence by 42%
United Kingdom
-
5 great cardio workouts you can do at home
United Kingdom
-
Online resources and coaching helped people seek genetic testing for cancer
United Kingdom